-
-
-
-
-
-
-
Spectranetics (SPNC) Appoints B. Kristine Johnson as new Chairperson of the Board
-
-
-
-
-
-
-
Spectranetics Reports Fourth Quarter 2016 Revenue of $71.9 million
-
-
-
-
-
-
-
Spectranetics Files PMA Application for FDA Approval of the Stellarex™ Drug-Coated Balloon
-
-
-
-
-
-
-
Spectranetics Receives CE Mark for AngioSculptX™
-
-
-
-
-
-
-
Spectranetics (SPNC) Announces Presentation of Positive Second Interim Analysis from ILLUMENATE Global Study
-
-
-
-
-
-
-
Needham & Company Reiterates Strong Buy Rating on Spectranetics (SPNC) Following Strong 4Q and Guidance
-
-
-
-
-
-
-
Spectranetics Announces FDA Submission of Bridge(TM) Occlusion Balloon for Lead Extraction Procedures
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

